Attic Incorporated

STUDENTS AS INVESTED LEARNERS FOR BETTER CLIMATE/SAIL FOR BETTER CLIMATE

CENTERS FOR INDEPENDENT LIVING - CENTERS FOR INDEPENDENT LIVING

THE MEDIEVAL SPAIN PROJECT

PHASE II: OPTIMIZATION OF A NANOPARTICLE-BASED TOPICAL PDE5I FORMULATION FOR TREATMENT OF ERECTILE DYSFUNCTION - ABSTRACT THIS PHASE II PROPOSAL IS A FOLLOW-UP TO THE SUCCESSFUL PHASE I STUDIES IN WHICH WE DEVELOPED A NOVEL TOPICALLY APPLIED SILDENAFIL-NANOPARTICLE (SILDENAFIL-NP) FORMULATION FOR IMPROVED TREATMENT OF ERECTILE DYSFUNCTION (ED). SILDENAFIL, INITIALLY ONLY USED FOR TREATMENT OF ED, IS NOW ALSO USED AT LOW ORAL DOSES IN PENILE REHABILITATION, A STRATEGY TO MAINTAIN ERECTILE TISSUE ARCHITECTURE AFTER RADICAL PROSTATECTOMY (RP). DESPITE ITS SAFETY, SILDENAFIL HAS SIDE EFFECTS SUCH AS HEADACHE AND FACIAL FLUSHING, AND IT HAS ISSUES WITH ABSORPTION AFFECTED BY DIET THAT CAN INCREASE TIME-TO-ERECTION. THESE DRAWBACKS COULD BE MITIGATED WITH THE TOPICAL SILDENAFIL-NP FORMULATION DEVELOPED IN THE PHASE I STUDY. THIS FORMULATION AIMS TO REDUCE SYSTEMIC SIDE EFFECTS, AVOID ABSORPTION VARIABILITY, BYPASS FIRST-PASS METABOLISM, AND PROVIDE A MORE DIRECT AND CONTINUOUS RELEASE OF SILDENAFIL. THE PHASE I STUDIES SUCCESSFULLY SHOWED THAT TOPICAL SILDENAFIL-NP IMPROVED ERECTILE FUNCTION IN AGING RATS. IN SPECIFIC AIM 1A OF THIS PHASE II PROPOSAL, WE WILL TEST THE EFFICACY OF SILDENAFIL-NP IN IMPROVING ERECTILE FUNCTION IN AN ANIMAL MODEL OF TYPE II DIABETES; AND IN SPECIFIC AIM 1B, OUR GOAL IS TO DEMONSTRATE THE EFFICACY OF SILDENAFIL- NP IN PRESERVING PENILE ARCHITECTURE AND FUNCTION AFTER CAVERNOUS NERVE INJURY, POTENTIALLY AIDING PENILE REHABILITATION FOLLOWING RP. IN SPECIFIC AIM 2 WE WILL SCALE UP THE MANUFACTURING CAPABILITY IN A GMP-COMPLIANT MANNER AND GENERATE A DEMONSTRATION BATCH OF SILDENAFIL-NP FOR USE IN ANIMAL SAFETY STUDIES. IN SPECIFIC AIM 3, WE WILL CONDUCT THE ANIMAL SAFETY STUDIES REQUIRED TO SUPPORT AN IND APPLICATION—SPECIFICALLY, WE WILL ASSESS THE POTENTIAL FOR SENSITIZATION IN A GUINEA PIG DERMAL HYPERSENSITIVITY STUDY AND ALSO ASSESS VAGINAL, ORAL, AND RECTAL IRRITATION BY REPEAT-DOSE IRRITATION STUDIES. FINALLY, IN SPECIFIC AIM 4, A PRE-IND MEETING WILL BE HELD WITH THE FDA TO GAIN BINDING INSIGHTS INTO REMAINING STEPS REQUIRED FOR AN IND APPLICATION AND INITIATION OF A PHASE I CLINICAL STUDY. BY THE END OF THIS PHASE II PROJECT: (1) THE EFFICACY OF TOPICAL SILDENAFIL-NP IN A DIABETIC RAT MODEL OF ED WILL BE ASSESSED AND THE ABILITY OF SILDENAFIL-NP TO PREVENT CHANGES IN MOLECULAR MARKERS OF ERECTILE FUNCTION AND GROSS PENILE ANATOMY FOLLOWING RP-RELATED INJURY WILL ALSO BE ASSESSED; (2) A DEMONSTRATION BATCH OF SILDENAFIL-NP WILL BE PRODUCED; (3) FOUR IND-ENABLING SAFETY STUDIES BE SUCCESSFULLY CONDUCTED; AND (4) FDA FEEDBACK FROM A PRE- IND MEETING WILL BE OBTAINED. SOON AFTER THE CONCLUSION OF THIS GRANT, ATTICUS WILL BE WELL POSITIONED TO FIND A DEVELOPMENT/COMMERCIALIZATION PARTNER THAT WILL FURTHER THE DEVELOPMENT OF SILDENAFIL-NP AND ADVANCE THE PROGRAM INTO CLINICAL TRIALS.

STTR PHASE II: SCALABLE DETECTOR FOR MULTIPLE-INPUT MULTIPLE-OUTPUT (MIMO) COMMUNICATION SYSTEMS

CAROL M. WHITE PHYSICAL EDUCATION PROGRAM

SBIR PHASE II: FULLY INTEGRATED DESIGN AND AUTOMATED FABRICATION SERVICES SOFTWARE PLATFORM FOR ENGINEERING LIVING SYSTEMS

YOU SHOULD NEVER BLINK [YOU SHOULD NEVER BLINK, IS A 90-MINUTE DOCUMENTARY FILM CHRONICLING THE LIFE AND LEGACY OF CORITA KENT. ARTIST, NUN, AND EDUCATOR, CORITA KENT (AKA SISTER CORITA) CAPTIVATED MID-CENTURY AMERICA WITH HER VIBRANT POP ART AND RADICAL IDEAS, ONLY TO BE LARGELY OMITTED FROM THE HISTORICAL NARRATIVE UNTIL NOW. IN HER OWN WORDS, AND THROUGH THE VOICES OF CONTEMPORARY ARTISTS AND KENT?S FORMER STUDENTS, YOU SHOULD NEVER BLINK RESURRECTS AND RECONSIDERS THE STORY OF THIS CULTURAL ICON.]

THE ARCHITECT AND THE PAINTER: THE CREATIVE LIVES OF CHARLES AND RAY EAMES

TEZUKA: GOD OF MANGA [CATTICUS CORPORATION SEEKS PRODUCTION FUNDING FOR A FEATURE LENGTH (80 MINUTE) DOCUMENTARY EXPLORING THE EXTRAORDINARY LIFE AND CAREER OF OSAMU TEZUKA (1928-1989), KNOWN IN JAPAN AS ?THE GOD OF MANGA.? ONE OF THE WORLD?S MOST PROLIFIC AND INFLUENTIAL STORYTELLERS, HIS WORK IS UNIVERSALLY CREDITED WITH ELEVATING JAPANESE COMICS AND ANIMATION TO THE HEIGHTS OF GLOBAL POPULAR CULTURE, INCLUDING IN THE U.S.]

ONE MORE MISSION [ONE MORE MISSION IS A ONE-HOUR DOCUMENTARY THAT EXPLORES THE RISE, IMPACT, AND LEGACY OF VIETNAM VETERANS AGAINST THE WAR (VVAW): THE FIRST AMERICAN VETERANS? ORGANIZATION TO DEMAND AN END TO THE WAR ITS MEMBERS HAD FOUGHT IN.]

AMERICAN REDS: THE FAILED REVOLUTION

MODERNISM, INC.

MAD AS HELL!

THE BARBARA JOHNS PROJECT [THE BARBARA JOHNS PROJECT WILL PRODUCE, TEST, ASSESS AND HOST AN EDUCATIONAL INTERACTIVE DOCUMENTARY WEBSITE TO ILLUMINATE A MISSING PIECE OF AMERICAN HISTORY OFTEN OVERLOOKED IN RACIAL DISCOURSE?THE AFRICAN AMERICAN STRUGGLE FOR FREEDOM DURING THE ERA OF SEGREGATION (JIM CROW) IN THE SOUTH BETWEEN THE CIVIL WAR AND THE CIVIL RIGHTS MOVEMENT.]

CENTERS FOR INDEPENDENT LIVING

ROBUST VISUAL PERCEPTION

MARATHON COUNTY COMMUNITY REENTRY PROGRAM

FY2023-2024 CENTERS FOR INDEPENDENT LIVING

FY 2025 ILCL ~ STATE PLAN INDEPENDENT LIVING CENTERS

FY2024-2025 CENTERS FOR INDEPENDENT LIVING

SBIR PHASE I: PROOF-OF-CONCEPT OF A CUSTOMIZABLE, NEXT-GENERATION RNA DELIVERY PARTICLE -THE BROADER IMPACT/COMMERCIAL POTENTIAL OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT IS THE CREATION OF A NOVEL RNA DRUG DELIVERY PLATFORM WITH IMPLICATIONS FOR TREATMENT OF CANCER AND OTHER VARIOUS DISEASES WITH UNMET MEDICAL NEED. CURRENT DELIVERY TECHNOLOGIES FAIL TO REALIZE THE POTENTIAL OF NUCLEIC ACID DRUGS BECAUSE OF LIMITATIONS LIKE TARGET SPECIFICITY, TOXICITY, AND ADMINISTRATION. NEXT GENERATION DELIVERY TECHNOLOGIES ARE ULTIMATELY REQUIRED TO ACHIEVE THE FULL THERAPEUTIC POTENTIAL OF NUCLEIC ACID DRUGS. THE TECHNOLOGY BEING DEVELOPED IN THIS PROJECT IS DESIGNED TO ADDRESS THE LIMITATIONS OF EXISTING DELIVERY MODALITIES, RESULTING IN A FLEXIBLE PLATFORM WITH TARGET- AND CARGO-CUSTOMIZATION READY FOR PROGRESSION TO EVALUATE MULTIPLE CLINICAL DISEASE TARGETS. THIS WILL EXPAND TREATMENT OPTIONS, INITIALLY FOR ONCOLOGY TARGETS, WITH FURTHER APPLICATIONS IN GENE EDITING AND VACCINES, AND CONTINUE TO ADDRESS EXISTING PATIENT NEEDS. THE TECHNOLOGY DEVELOPED IN THIS PROJECT HAS THE POTENTIAL TO EXPAND THE NUCLEIC ACID DELIVERY MARKET AND RESULT IN IMPROVEMENTS TO LENGTH AND QUALITY OF LIFE FOR INDIVIDUALS FACING LIFE-THREATENING DISEASES IN MULTIPLE THERAPEUTIC AREAS IN BOTH THE UNITED STATES AND GLOBALLY. THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT WILL ADDRESS THE PROOF-OF-CONCEPT MILESTONES REQUIRED TO VALIDATE DELIVERY OF RNA CARGOES TO TARGET CELLS USING AN ENGINEERABLE PROTEIN NANOPARTICLE. THE PARTICLE PLATFORM HAS SEVERAL KEY ATTRIBUTES INCORPORATED THAT ENABLE EFFICIENT AND TARGETED DELIVERY, AND WHICH ARE REQUIRED FOR FULL PLATFORM FUNCTIONALITY: 1) THE ABILITY TO PACKAGE NUCLEIC ACID, 2) DISPLAY OF TARGETING MOIETY, AND 3) THE ABILITY TO DISASSEMBLE WITHIN THE INTRACELLULAR ENVIRONMENT AND RELEASE NUCLEIC ACID CARGOES. IN THIS PROJECT, PARTICLES ENGINEERED TO TARGET SPECIFIC CANCER CELL SURFACE MARKERS WILL BE 1) IN VITRO LOADED WITH MRNA CARGOES, 2) EVALUATED IN VITRO FOR DELIVERY OF RNA CARGOES TO SPECIFIC CANCER CELLS, 3) EVALUATED IN VIVO FOR DELIVERY OF RNA CARGOES TO TARGET TUMORS WITH EXCEPTIONAL SPECIFICITY, AND 4) EVALUATED IN VIVO FOR EFFICACY OF THERAPEUTIC RNA DELIVERY. THE RESULT OF THIS PROJECT WILL BE A VALIDATED CUSTOMIZABLE DELIVERY PLATFORM POSITIONED FOR CLINICAL DEVELOPMENT AGAINST MULTIPLE TARGETS. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.

SBIR PHASE I: CORNEAL TISSUE RESTORATION WITH ENGINEERED TISSUE -THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT INCLUDES REDUCES THE FINANCIAL BURDEN OF CORNEA BLINDNESS AND ADVANCES THE MEDICAL DEVICE MANUFACTURING INDUSTRY IN THE US. VISION LOSS COSTS COMMUNITIES IN LOST WAGES AND MEDICAL EXPENSES. IN 2018, THE COMBINED COST FOR BLINDNESS AND MSVI (MODERATE AND SEVERE VISION IMPAIRMENT) WAS $55.51 BILLION IN NORTH AMERICA. BY PROVIDING A TREATMENT FOR CORNEA BLINDNESS EQUIVALENT TO S DONOR CORNEA, THIS INNOVATION WOULD HELP RESTORE THE VISION OF PATIENTS AFFECTED BY CORNEAL BLINDNESS, IMPROVE THEIR ABILITY TO CONTRIBUTE TO SOCIETY, AND LOWER THE BURDEN ON THEIR CARETAKERS. IN ADDITION, BY CONTRIBUTING TO THE GENERAL PROCESS OF TISSUE ENGINEERING, THE ENGINEERED CORNEA WILL HELP FOSTER RESEARCH IN THE FIELD OF ALTERNATIVES TO DONOR TISSUES, WHICH WILL CONTRIBUTE TO THE WELL-BEING OF INDIVIDUALS IN SOCIETY AS A WHOLE. THE DEVELOPMENT OF ENGINEERED CORNEA WOULD ALSO HELP ADVANCE THE POSITION OF THE US IN THE CORNEA REPLACEMENT MATERIAL FIELD AND MORE GENERALLY IN THE ENGINEERED TISSUE RESEARCH FIELD AND COULD RESULT IN GROWTH OPPORTUNITIES IN THE MEDICAL DEVICE MANUFACTURING INDUSTRY, THEREFORE INCREASING US COMPETITIVENESS. THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT CREATES A NOVEL ACELLULAR POLYMER MEMBRANE FOR USE AS A CORNEA SUBSTITUTE. THE ARTIFICIAL CORNEA WILL DIFFERENTIATE ITSELF FROM OTHER ARTIFICIAL CORNEA OPTIONS BY OFFERING A TRUE ALTERNATIVE TO DONOR CORNEA FOR FULL THICKNESS CORNEA REPLACEMENT (ALSO KNOWN AS PENETRATING KERATOPLASTY). THE ARTIFICIAL CORNEA WILL CONSIST OF A CROSSLINKED POLYMER MEMBRANE THAT WILL PROVIDE BIOCOMPATIBILITY WITH OCULAR TISSUES AND SUTURABILITY SIMILAR TO A DONOR CORNEA. IN ADDITION, SPECIFIC SURFACE MODIFICATIONS WILL BE ADDED TO THE MEMBRANE TO MAINTAIN ITS OPTICAL CLARITY, BY PREVENTING THE ADHESION OF ENVIRONMENTAL AND BIOLOGICAL CONTAMINANTS. THESE MODIFICATIONS WILL ENABLE SECURE INTEGRATION INTO THE PATIENT?S EYE. THE NEW MATERIALS WILL BE AESTHETICALLY EQUIVALENT TO EXISTING DONOR CORNEA. BY CONTRAST TO CURRENT ARTIFICIAL CORNEA OPTIONS, THE ARTIFICIAL CORNEA AIMS TO PROVIDE A TRUE REPLACEMENT TO DONOR CORNEA THAT CAN BE USED AS A STANDARD OF CARE TREATMENT FOR FULL THICKNESS CORNEA REPLACEMENT, WITHOUT THE RISKS GENERALLY ASSOCIATED WITH DONOR CORNEA TISSUE AND WITHOUT THE NEED FOR REFRIGERATION OR COMPLICATED TRANSPORT LOGISTICS. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE PLANNED FOR THIS AWARD.

FY2022-2023 CENTERS FOR INDEPENDENT LIVING

2020 CILS

2019 CENTERS FOR INDEPENDENT LIVING

2021 CILS

2018 CENTERS FOR INDEPENDENT LIVING

SBIR PHASE I: MACHINE LEARNING-POWERED SIMULATION OF ADDITIVE MANUFACTURING FOR REAL-TIME DESIGN AND PROCESS OPTIMIZATION -THE BROADER IMPACT OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT IS TO ACCELERATE LARGER-SCALE ADOPTION OF ADDITIVE MANUFACTURING (AM) THROUGH ULTRAFAST ENGINEERING SIMULATION SOFTWARE. THE AM INDUSTRY WAS WORTH $12.6 BILLION IN 2020 AND HOLDS GREAT POTENTIAL IN PROVIDING ADVANCED DESIGNS AND ENABLING DISTRIBUTED SUPPLY CHAINS FOR THE US AEROSPACE, MEDICAL, AND AUTOMOTIVE INDUSTRIES. HOWEVER, AM IS FACING SLOW ADOPTION DUE TO TRIAL AND ERROR PROCESSES CASUED BY THE LACK OF AN EFFICIENT AND RELIABLE ENGINEERING WORKFLOW. THE PROPOSED ULTRAFAST SIMULATION TECHNOLOGY MAY PROVIDE REAL-TIME PREDICTIONS OF POSSIBLE MANUFACTURING ISSUES FOR AM PARTS IN THE DESIGN PHASE, THEREBY REDUCING MANUFACTURING FAILURES AND PROTOTYPING. THE PROJECT ALSO SEEKS TO GENERATE SYSTEMATIC KNOWLEDGE OF HOW MACHINE LEARNING CAN HELP OVERCOME SOME LONG-LASTING FUNDAMENTAL CHALLENGES IN SCIENTIFIC COMPUTING AND HELP ADVANCE ENGINEERING SOFTWARE USED FOR DIGITAL MANUFACTURING. THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT INTEGRATES MACHINE LEARNING WITH FINITE ELEMENT METHODS (FEM) TO DEVELOP A PROOF-OF-CONCEPT FOR 3-5 ORDERS OF MAGNITUDE FASTER PROCESS SIMULATION SOFTWARE FOR AM USED TO PREDICT MANUFACTURING FAILURES DUE TO HIGH TEMPERATURE, RESIDUAL DISTORTION, AND RESIDUAL STRESSES. THE TRADITIONAL COMPUTATION METHOD FOR PART-SCALE AM SIMULATION TAKES HOURS TO DAYS AND RELIES ON AN ITERATIVE, LAYER-WISE APPROACH. THE PROPOSED PROJECT SEEKS TO REPLACE THE MOST TIME-CONSUMING STEPS IN THE TRADITIONAL SIMULATION METHOD WITH DEEP LEARNING AND IMPLEMENT A ONE-STEP APPROACH. THE PROPOSED HYBRID DATA-DRIVEN PLUS PHYSICAL SIMULATION FRAMEWORK INCLUDES THE DEVELOPMENT A FEATURE-DRIVEN, DEEP LEARNING MODEL AND A PROCESS PARAMETER-BASED TRANSFER LEARNING MODEL, AND COUPLING THESE MODELS WITH THE FINITE ELEMENT METHOD. THE PROJECT ALSO AIMS TO APPLY AND BENCHMARK HYBRID DATASETS FROM AM PHYSICAL MODELLING, THREE-DIMENTIONAL (3D) SCANNING OF MANUFACTURED PARTS, AND IN-SITU MONITORING FOR TRAINING AND MODEL SCALABILITY. THE TEAM SEEKS TO DEMONSTRATE TECHNOLOGICAL ADVANTAGES THROUGH PILOT TESTING WITH STREAMLINED USER INTERFACES AND APPLICATION PROGRAMMING INTERFACES (APIS) DEVELOPED IN THIS PROJECT. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.

2020 ILC3 - CARES

SBIR PHASE I: AUTOMATED ASSEMBLY OF DISCRETE CELLULAR STRUCTURES

2017 CENTERS FOR INDEPENDENT LIVING

DEVELOPMENT OF A SECURE, CLOUD-BASED PLATFORM TO IMPROVE RECORD LINKAGE & CROSS-AGENCY COLLABORATION FOR THE PUBLIC SECTOR: USING DEEP LEARNING & SCALABLE DATA INTEGRATIONS TO COMBAT THE OPIOID CRISIS

STTR PHASE I: SCALABLE DETECTOR FOR MULTIPLE-INPUT MULTIPLE-OUTPUT (MIMO) COMMUNICATION SYSTEMS

COMMUNITY FACILITIES - NATURAL DISASTER GRANTS

SBIR PHASE I: COMMERCIALIZATION OF BIO-DESIGN AUTOMATION SOFTWARE FOR SYNTHETIC BIOLOGY

REAP IRA RES GRANT UNRESTRICTED (FY 25)

BEYOND SCREEN TIME: DEVELOPING AN OBJECTIVE MOBILE MEDIA MEASUREMENT TOOL

ASSISTANCE TO FIREFIGHTERS GRANT

STRIKING BACK, STRIDING FORWARD [THE PROPOSED I-DOC INTERACTIVE WEBSITE TELLS THE STORY OF BARBARA JOHNS, A 16-YEAR OLD STUDENT WHO ORGANIZED A STUDENT PROTEST AGAINS HER SEGREGATED SCHOOL IN FARMVILLE, VIRGINIA IN 1951 THAT LED TO THE SUPREME COURT DECLARING SEGREGATION IN PUBLIC EDUCATION UNCONSTITUTIONAL.]

RBCS REAP IRA TECH ASSIST GRANTS

ASSISTANCE TO FIREFIGHTERS GRANT

AMERICAN REDS: THE FAILED REVOLUTION, 1920-1956

ONE MORE MISSION [ONE MORE MISSION EXPLORES THE RISE, IMPACT, AND LEGACY OF VIETNAM VETERANS AGAINST THE WAR: THE FIRST VETERANS? GROUP IN AMERICAN HISTORY TO DEMAND AN END TO THE WAR ITS MEMBERS HAD FOUGHT IN.]

YOU SHOULD NEVER BLINK [YOU SHOULD NEVER BLINK PRESENTS THE REBELLIOUS LIFE OF NUN, ARTIST, AND EDUCATOR, CORITA KENT, ALSO KNOWN AS SISTER CORITA (1918-1986). FROM A WORKING POOR FAMILY, CORITA HARNESSED HER CREATIVITY AND FAITH TO BUILD A LIFE AS AN ARTIST. BY THE 1960S SHE WAS A CULTURAL ICON, GRACING THE COVER OF NEWSWEEK AND PIONEERING A SOCIALLY-ENGAGED ART PRACTICE. BUT HER CONTRIBUTION IS TOO OFTEN OVERLOOKED, AND SHE IS AT RISK OF BEING FORGOTTEN. COMBINING ARCHIVAL FOOTAGE, INTERVIEWS, AND ANIMATED SEQUENCES THAT WILL BRING NEWLY DIGITIZED PHOTOGRAPHS BY CORITA TO LIFE, THIS DOCUMENTARY REINSERTS THE JOYFUL ART AND ACTIVISM OF CORITA INTO THE NARRATIVE. SHE STILL HAS SO MUCH TO TEACH US.]

TEZUKA: GOD OF MANGA [THE PRODUCERS SEEK DEVELOPMENT FUNDING FOR A FEATURE LENGTH (82 MINUTE) DOCUMENTARY EXPLORING THE EXTRAORDINARY LIFE AND CAREER OF OSAMU TEZUKA (1928-1989), KNOWN IN JAPAN AS ?THE GOD OF MANGA.? ONE OF THE WORLD?S MOST PROLIFIC AND INFLUENTIAL STORYTELLERS, HIS WORK IS UNIVERSALLY CREDITED WITH ELEVATING JAPANESE COMICS AND ANIMATION TO THE HEIGHTS OF GLOBAL POPULAR CULTURE, INCLUDING IN THE U.S.]

MODERNISM INC.

LAMP VALUE-ADDED PRODUCER GRANTS - COVID

ASSISTANCE TO FIREFIGHTERS GRANT

MAD AS HELL!: HOWARD JARVIS AND THE BIRTH OF THE TAX REVOLT

COMMUNITY FACILITY GRANTS

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

COMMUNITY FACILITY GRANTS

TO SUPPORT PRODUCTION AND POST-PRODUCTION COSTS FOR A FEATURE-LENGTH DOCUMENTARY ABOUT THE MARK MORRIS DANCE GROUP WORKING WITH PEOPLE WHO HAVE PARKI

COMMUNITY FACILITY GRANTS

SRSA APPLICATION

COMMUNITY FACILITY GRANTS

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

SRSA APPLICANT

SRSA APPLICATION

APPLICATION FOR SMALL RURAL SCHOOL ACHIEVEMENT PROGRAM

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

APPLICATION FOR SMALL RURAL SCHOOL ACHIEVEMENT PROGRAM

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

TO SUPPORT THE COMPLETION OF A DOCUMENTARY FILM TITLED, "THE ARCHITECT AND THE PAINTER: THE CREATIVE LIVES OF CHARLES AND RAY EAMES."

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

APPLICATION FOR SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

APPLICATION FOR SMALL RURAL SCHOOL ACHIEVEMENT PROGRAM

APPLICATION FOR SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

APPLICATION FOR SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

APPLICATION FOR SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

THIS GRANT SUPPORTS THE COSTS INCURRED TO IMPLEMENT MEASURES TO RESPOND TO THE NOVEL CORONAVIRUS 2019 (COVID-19), WHICH MAY INCLUDE WORKPLACE SAFETY, MARKET PIVOTS, RETROFITTING FACILITIES, TRANSPORTATION, WORKER HOUSING, AND MEDICAL EXPENSES. IT PROVIDES NEEDED RELIEF TO THE FOOD PROCESSORS, DISTRIBUTORS, FARMERS MARKETS, AND PRODUCERS FOR THEIR COSTS INCURRED BETWEEN JANUARY 27, 2020, THE DATE UPON WHICH THE PUBLIC HEALTH EMERGENCY WAS DECLARED BY THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICE (HHS) UNDER SECTION 319 OF THE PUBLIC HEALTH SERVICE ACT, AND DECEMBER 31, 2021. BENEFICIARIES INCLUDE THE EMPLOYEES OF THE FOOD PROCESSORS, DISTRIBUTORS, FARMERS MARKETS, AND PRODUCERS.

SEC 9007 REAP-RENEW ENERGY EFFICIENCY IMPROVE GRANTS, $20,000 OR LESS (MAN)

APPLICATION FOR SMALL, RURAL SCHOOL ACHIEVEMENT PROGRAM

SEC 9007 REAP-RENEW ENERGY EFFICIENCY IMPROVE GRANTS, $20,000 OR LESS (MAN)

FY21 PART C CILS ACCESS TO COVID 19 VACCINES

2016 CENTERS FOR INDEPENDENT LIVING